Factors in response to treatment of early postmenopausal bone loss.
D000469:Alkaline Phosphatase / Q000097:blood; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000652:urine; D002762:Cholecalciferol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism*; D010024:Osteoporosis / Q000188:drug therapy* / Q000378:metabolism; D010710:Phosphates / Q000097:blood; D012969:Sodium Fluoride / Q000627:therapeutic use
D004967:Estrogens; D008903:Minerals; D010710:Phosphates; D002762:Cholecalciferol; D001539:Bendroflumethiazide; D012969:Sodium Fluoride; D000469:Alkaline Phosphatase; D002118:Calcium